Purchase Order HHSN272201701177P
Award Date 9/7/17
Potential Completion Date 9/29/17
Potential Value $9.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98168, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The $6,699 firm fixed-price contract is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research, particularly in areas like immunology and infectious disease investigations....
- The U.S. National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract worth $14,934.75 to Stemcell Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the supply of the EASYSEP NEGATIVE HUMAN CD4 KIT, Catalog #19052. This product supports biomedical and scientific research, particularly in areas like infectious diseases,...
- This federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS). The $24,536.00 firm fixed-price purchase order is for the provision of the AMBIS 1787964 QUOTE Q-921198 item, which is described as the "EASY STEP NEGATIVE HUMAN CD4 KIT". The award does not have a small business set-aside designation. Stemcell...
- This federal contract award, valued at $22,786.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the delivery of the EasySep Negative Human CD4 Kit, a specialized cell isolation product used to support biomedical research initiatives, particularly in the areas of immunology, infectious disease, and stem cell studies. The...
- This federal contract award, valued at $11,170.80, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which is not set aside for small businesses, is for the provision of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various government agencies, particularly within the Department of...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, valued at $5,636.00, is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research. Stemcell Technologies Inc....
- This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $17,450.00 Firm Fixed Price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit organization, for the delivery of HUMAN CD8 KITS. The contract has a completion date of June 22, 2018 and does not have a set-aside designation. Stemcell Technologies Inc. is an active supplier of specialized biological materials, laboratory...
- This is a federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of an EasySep Negative Human CD4 Kit, catalog number 19052. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract has a ceiling value of $39,906.40 and is structured as a firm fixed price purchase order. The contract is...
- This federal contract award was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research products. The contract, which is a Blanket Purchase Agreement (BPA) with a ceiling value of $10,000,000, authorizes Stemcell Technologies Inc. to provide a comprehensive range of biological materials, blood and blood products, laboratory supplies, media, and...